Yamamoto-Furusho J K, Bosques-Padilla F, de-Paula J, Galiano M T, Ibañez P, Juliao F, Kotze P G, Rocha J L, Steinwurz F, Veitia G, Zaltman C
Clínica de Enfermedad Inflamatoria Intestinal, Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
Gastroenterology Division, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México; Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, Monterrey, México.
Rev Gastroenterol Mex. 2017 Jan-Mar;82(1):46-84. doi: 10.1016/j.rgmx.2016.07.003. Epub 2016 Dec 13.
The incidence and prevalence of inflammatory bowel disease (IBD) has increased in recent years in several Latin American countries. There is a need to raise awareness in gastroenterologists and the population in general, so that early diagnosis and treatment of ulcerative colitis (UC) and Crohn's Disease (CD) can be carried out. It is important for all physicians to have homogeneous criteria regarding the diagnosis and treatment of IBD in Latin America. The Pan American Crohn's and Colitis Organisation (PANCCO) is an organization that aims to include all the countries of the Americas, but it specifically concentrates on Latin America. The present Consensus was divided into two parts for publication: 1) Diagnosis and treatment and 2) Special situations. This is the first Latin American Consensus whose purpose is to promote a perspective adapted to our Latin American countries for the diagnosis, treatment, and monitoring of patients with UC and CD.
近年来，炎症性肠病（IBD）在几个拉丁美洲国家的发病率和患病率有所上升。有必要提高胃肠病学家和普通民众的认识，以便能够对溃疡性结肠炎（UC）和克罗恩病（CD）进行早期诊断和治疗。对于所有医生来说，在拉丁美洲对IBD的诊断和治疗采用统一标准非常重要。泛美克罗恩病和结肠炎组织（PANCCO）是一个旨在涵盖美洲所有国家的组织，但它特别专注于拉丁美洲。本共识分为两部分出版：1）诊断与治疗；2）特殊情况。这是首个拉丁美洲共识，其目的是促进一种适用于我们拉丁美洲国家的对UC和CD患者的诊断、治疗及监测的观点。
